Role of NK and NKT cells in the immunopathogenesis of HCV-induced hepatitis
- 24 June 2004
- journal article
- review article
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 76 (4) , 743-759
- https://doi.org/10.1189/jlb.0304197
Abstract
Natural killer (NK) cells constitute the first line of host defense against invading pathogens. They usually become activated in an early phase of a viral infection. Liver is particularly enriched in NK cells, which are activated by hepatotropic viruses such as hepatitis C virus (HCV). The activated NK cells play an essential role in recruiting virus-specific T cells and in inducing antiviral immunity in liver. They also eliminate virus-infected hepatocytes directly by cytolytic mechanisms and indirectly by secreting cytokines, which induce an antiviral state in host cells. Therefore, optimally activated NK cells are important in limiting viral replication in this organ. This notion is supported by the observations that interferon treatment is effective in HCV-infected persons in whom it increases NK cell activity. Not surprisingly, HCV has evolved multiple strategies to counter host's NK cell response. Compromised NK cell functions have been reported in chronic HCV-infected individuals. It is ironic that activated NK cells may also contribute toward liver injury. Further studies are needed to understand the role of these cells in host defense and in liver pathology in HCV infections. Recent advances in understanding NK cell biology have opened new avenues for boosting innate and adaptive antiviral immune responses in HCV-infected individuals.Keywords
Funding Information
- “Fonds de la recherche en Santé du Québec”
- laboratory for insightful discussions
- Canadian Institutes of Health Research
This publication has 175 references indexed in Scilit:
- Expression and role of MICA and MICB in human hepatocellular carcinomas and their regulation by retinoic acidInternational Journal of Cancer, 2003
- Intrahepatic T Cells in Hepatitis BThe Journal of Experimental Medicine, 2000
- Role of Transforming Growth Factor β Type Ii Receptor in Hepatic Fibrosis: Studies of Human Chronic Hepatitis C and Experimental Fibrosis in RatsHepatology, 1999
- NATURAL KILLER CELLS IN ANTIVIRAL DEFENSE: Function and Regulation by Innate CytokinesAnnual Review of Immunology, 1999
- Repression of the PKR protein kinase by the hepatitis C virus NS5A protein: a potential mechanism of interferon resistanceClinical and Diagnostic Virology, 1998
- Activation-induced NK cell death triggered by CD2 stimulationEuropean Journal of Immunology, 1998
- Early Murine Cytomegalovirus (MCMV) Infection Induces Liver Natural Killer (NK) Cell Inflammation and Protection Through Macrophage Inflammatory Protein 1α (MIP-1α)–dependent PathwaysThe Journal of Experimental Medicine, 1998
- Effectiveness of interferon-alpha therapy in chronic hepatitis C is associated with the amount of interferon-alpha receptor mRNA in the liverJournal of Hepatology, 1997
- Fas-mediated cytotoxicity by freshly isolated natural killer cells.The Journal of Experimental Medicine, 1995
- Intrahepatic mononuclear cell populations and MHC antigen expression in patients with chronic hepatitis B: Effect of interferon-αDigestive Diseases and Sciences, 1994